Paper32917954
Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
Bongiovanni D and 6 others. Oncogene, 2020. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia. Papers, record 32917954. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32917954
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Hedgehog Proteins | Major topic |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Receptors, Glucocorticoid | Major topic |
| Signal Transduction | Major topic |
| Acetylation | |
| Animals | |
| Cell Line, Tumor | |
| Dexamethasone | |
| Drug Synergism | |
| Gene Expression Regulation, Leukemic | |
| Histone Deacetylase 1 | |
| Humans | |
| Mice | |
| Protein Stability | |
| Pyridines | |
| Pyrimidines | |
| Xenograft Model Antitumor Assays | |
| Zinc Finger Protein GLI1 | |
| p300-CBP Transcription Factors | |
| p300-CBP-Associated Factor |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15691355 | Hedgehog signaling and congenital malformations. | Clin Genet | 2005 | https://conductscience.org/library/papers/15691355 | PubMed |
| 2 | 21257310 | Hedgehog morphogen: from secretion to reception. | Trends Cell Biol | 2011 | https://conductscience.org/library/papers/21257310 | PubMed |
| 3 | 22391305 | Hedgehog/Gli control by ubiquitination/acetylation interplay. | Vitam Horm | 2012 | https://conductscience.org/library/papers/22391305 | PubMed |
| 4 | 17622575 | Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? | Mol Pharmacol | 2007 | https://conductscience.org/library/papers/17622575 | PubMed |
| 5 | 30304769 | A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia. | Cells | 2018 | https://conductscience.org/library/papers/30304769 | PubMed |
| 6 | 26465987 | Acute Lymphoblastic Leukemia in Children. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26465987 | PubMed |
| 7 | 24202394 | Unraveling the therapeutic potential of the Hedgehog pathway in cancer. | Nat Med | 2013 | https://conductscience.org/library/papers/24202394 | PubMed |
| 8 | 27451956 | The genetics and mechanisms of T cell acute lymphoblastic leukaemia. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27451956 | PubMed |
| 9 | 25660620 | Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy. | Expert Rev Mol Med | 2015 | https://conductscience.org/library/papers/25660620 | PubMed |
| 10 | 18677410 | Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18677410 | PubMed |
| 11 | 19074837 | Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. | Mol Cancer Res | 2008 | https://conductscience.org/library/papers/19074837 | PubMed |
| 12 | 12435629 | Dorsal-ventral patterning of the spinal cord requires Gli3 transcriptional repressor activity. | Genes Dev | 2002 | https://conductscience.org/library/papers/12435629 | PubMed |
| 13 | 21169257 | The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/21169257 | PubMed |
| 14 | 20947430 | Glucocorticoid use in acute lymphoblastic leukaemia. | Lancet Oncol | 2010 | https://conductscience.org/library/papers/20947430 | PubMed |
| 15 | 29654263 | Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia. | Leukemia | 2018 | https://conductscience.org/library/papers/29654263 | PubMed |
| 16 | 17873912 | Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling. | Oncogene | 2008 | https://conductscience.org/library/papers/17873912 | PubMed |
| 17 | 8269518 | Sonic hedgehog mediates the polarizing activity of the ZPA. | Cell | 1993 | https://conductscience.org/library/papers/8269518 | PubMed |
| 18 | 25183867 | Roles for Hedgehog signaling in adult organ homeostasis and repair. | Development | 2014 | https://conductscience.org/library/papers/25183867 | PubMed |
| 19 | 20170710 | Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia. | Mol Cell Endocrinol | 2010 | https://conductscience.org/library/papers/20170710 | PubMed |
| 20 | 2668288 | Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially expressed receptor fragment. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2668288 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42509807 | High Corticosterone Affects Somite Development During Early Avian Embryogenesis. | Biomolecules | 2026 | https://conductscience.org/library/papers/42509807 | PubMed |
| 38994763 | Hedgehog pathway and cancer: A new area (Review). | Oncol Rep | 2024 | https://conductscience.org/library/papers/38994763 | PubMed |
| 37717739 | Modulating glucocorticoid receptor actions in physiology and pathology: Insights from coregulators. | Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37717739 | PubMed |
| 37476499 | The hidden hedgehog of the pituitary: hedgehog signaling in development, adulthood and disease of the hypothalamic-pituitary axis. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37476499 | PubMed |
| 37359189 | Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia. | Hemasphere | 2023 | https://conductscience.org/library/papers/37359189 | PubMed |
| 37345151 | Beyond Corticoresistance, A Paradoxical Corticosensitivity Induced by Corticosteroid Therapy in Pediatric Acute Lymphoblastic Leukemias. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37345151 | PubMed |
| 36769284 | Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL). | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769284 | PubMed |
| 36640905 | Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators. | Transl Res | 2023 | https://conductscience.org/library/papers/36640905 | PubMed |
| 34203724 | Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5'AMP-Activated Kinase Inactivation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34203724 | PubMed |
| 33968167 | Salidroside overcomes dexamethasone resistance in T-acute lymphoblastic leukemia cells. | Exp Ther Med | 2021 | https://conductscience.org/library/papers/33968167 | PubMed |
| 33906306 | Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F). | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/33906306 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GLI1 | 2735 | PubTator's text mining | https://conductscience.org/library/genes/2735 | NCBI Gene |
| HDAC1 | 3065 | PubTator's text mining | https://conductscience.org/library/genes/3065 | NCBI Gene |
| KAT2B | 8850 | PubTator's text mining | https://conductscience.org/library/genes/8850 | NCBI Gene |
| NR3C1 | 2908 | PubTator's text mining | https://conductscience.org/library/genes/2908 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32917954
GET https://conductscience.org/api/papers/v1/32917954/references?page=2